Quotes 5-day view Delayed Nasdaq
06/23/2022
06/24/2022
06/27/2022
06/28/2022
06/29/2022
Date
54.95(c)
54.91(c)
54.95(c)
54.96(c)
54.97(c)
Last
184 731
2 379 177
326 717
281 516
594 648
Volume
+0.02%
-0.07%
+0.07%
+0.02%
+0.02%
Change
Estimated financial data (e) (USD)
Sales 2022
-
-
-
Net income 2022
-98,9 M
-
-
Net Debt 2022
-
-
-
P/E ratio 2022
-11,5x
Yield 2022
-
Sales 2023
28,7 M
-
-
Net income 2023
-88,2 M
-
-
Net Debt 2023
-
-
-
P/E ratio 2023
-14,2x
Yield 2023
-
Capitalization
1 342 M
1 342 M
-
Capi. / Sales 2022
-
Capi. / Sales 2023
46,8x
Nbr of Employees
109
Free-Float
91,4%
Sierra Oncology, Inc. is late stage drug development company. The Company is focused on advancing targeted therapeutics for the treatment of patients with unmet medical needs in hematology and oncology. Momelotinib, the Company’s lead drug candidate, is a potent, selective and orally-bioavailable janus kinase one (JAK1), janus kinase two (JAK2) and activin a receptor type one (ACVR1) inhibitor with a...
Ratings of Sierra Oncology, Inc.
All news about SIERRA ONCOLOGY, INC.
06/29 Sierra Oncology Shareholders Approve Acquisition by GSK MT
06/29 SIERRA ONCOLOGY, INC. : Submission of Matters to a Vote of Security Holders, Other Events ..AQ
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell Small Cap Comp Growth IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) dropped from Russell Microcap Value IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 3000 Growth IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 2000 Dynamic IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 2000 IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 2000 Growth IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 3000E IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) dropped from Russell 3000E Value IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 3000E Growth IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 3000 IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell Small Cap Completeness IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 2500 Growth IndexCI
06/24 SIERRA ONCOLOGY, INC.(NASDAQGM : SRRA) added to Russell 2500 IndexCI
News in other languages on SIERRA ONCOLOGY, INC.
Analyst Recommendations on SIERRA ONCOLOGY, INC.
Pfizer to sell stake in GSK's consumer health business after it lists
Chart SIERRA ONCOLOGY, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends SIERRA ONCOLOGY, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
54,97 $
Average target price
55,00 $
Spread / Average Target
0,05%
Please enable JavaScript in your browser's settings to use dynamic charts.